Article
Early tumor shrinkage in patients with metastatic colorectal cancer receiving first-line treatment with cetuximab combined with either CAPIRI or CAPOX: an analysis of the German AIO KRK 0104 trial.
Acta oncologica (Stockholm, Sweden) - 1 Jun 2013
Modest Dominik P, Laubender Ruediger P, Stintzing Sebastian, Giessen Clemens, Schulz Christoph, Haas Michael, Mansmann Ulrich, Heinemann Volker
Abstract excerpt
PURPOSE: This study investigated the impact of early tumor shrinkage (ETS) on progression-free- (PFS) and overall survival (OS) in patients with metastatic colorectal cancer (mCRC) treated within the AIO KRK 0104 trial as first-line therapy. Moreover, correlations of ETS with clinical characteristics and prognostic markers were evaluated. PATIENTS AND METHODS: In total, 121 patients were included into this...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.